FI51046C - Menetelmä asetosalisyylihappotabletin valmistamiseksi. - Google Patents

Menetelmä asetosalisyylihappotabletin valmistamiseksi.

Info

Publication number
FI51046C
FI51046C FI650179A FI17965A FI51046C FI 51046 C FI51046 C FI 51046C FI 650179 A FI650179 A FI 650179A FI 17965 A FI17965 A FI 17965A FI 51046 C FI51046 C FI 51046C
Authority
FI
Finland
Prior art keywords
acetocalicylic
preparation
acid tablet
tablet
acid
Prior art date
Application number
FI650179A
Other languages
English (en)
Swedish (sv)
Other versions
FI51046B (fi
Inventor
Eugene Howard Gans
Henry M Apelian
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Application granted granted Critical
Publication of FI51046B publication Critical patent/FI51046B/fi
Publication of FI51046C publication Critical patent/FI51046C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI650179A 1964-01-27 1965-01-26 Menetelmä asetosalisyylihappotabletin valmistamiseksi. FI51046C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US340496A US3388041A (en) 1964-01-27 1964-01-27 High dosage sustained release tablet

Publications (2)

Publication Number Publication Date
FI51046B FI51046B (fi) 1976-06-30
FI51046C true FI51046C (fi) 1976-10-11

Family

ID=23333604

Family Applications (1)

Application Number Title Priority Date Filing Date
FI650179A FI51046C (fi) 1964-01-27 1965-01-26 Menetelmä asetosalisyylihappotabletin valmistamiseksi.

Country Status (9)

Country Link
US (1) US3388041A (fi)
BE (1) BE658905A (fi)
BR (1) BR6566484D0 (fi)
DE (1) DE1492107C3 (fi)
ES (1) ES308585A1 (fi)
FI (1) FI51046C (fi)
FR (1) FR4768M (fi)
GB (1) GB1070492A (fi)
SE (1) SE375236B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449489A (en) * 1965-10-21 1969-06-10 William E Gaunt Pharmaceutical compositions and their preparation
US3523141A (en) * 1967-04-26 1970-08-04 Nippon Zeon Co Method for inhibiting polymerization of conjugated dienes
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
US4248856A (en) * 1979-07-10 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
JPS5661311A (en) * 1979-10-25 1981-05-26 Fujisawa Pharmaceut Co Ltd Thial amide or prolonged pharmaceutical preparation comprising its salt
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
JPS57500432A (fi) * 1980-03-20 1982-03-11
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US4302440B1 (en) * 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
FR2723586A1 (fr) * 1994-08-11 1996-02-16 Seth Pawan Nouvelles compositions contenant de la cimetidine et associations en derivant
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
IN186245B (fi) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US8148393B2 (en) * 2005-11-18 2012-04-03 Synthon Bv Zolpidem tablets

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798443A (en) * 1954-07-21 1957-07-09 Smith Kline French Lab Multilayer tablet compressing machine
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
BE627516A (fi) * 1962-01-25
US3115441A (en) * 1962-06-06 1963-12-24 Victor M Hermelin Timed release pharmaceutical preparations and method of making the same

Also Published As

Publication number Publication date
DE1492107A1 (de) 1969-07-17
ES308585A1 (es) 1965-08-16
DE1492107B2 (de) 1973-04-26
DE1492107C3 (de) 1973-12-06
FR4768M (fi) 1967-01-23
US3388041A (en) 1968-06-11
GB1070492A (en) 1967-06-01
SE375236B (fi) 1975-04-14
BE658905A (fi) 1965-07-27
FI51046B (fi) 1976-06-30
BR6566484D0 (pt) 1973-07-17

Similar Documents

Publication Publication Date Title
FI51046C (fi) Menetelmä asetosalisyylihappotabletin valmistamiseksi.
FI48590C (fi) Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi.
DK136901B (da) Analogifremgangsmåde til fremstilling af 2-anilinonikotinsyrederivater.
DK122766B (da) Analogifremgangsmåde til fremstilling af oksazolalkansyrederivater.
FI50334C (fi) Menetelmä 1-hydroksi-2pyridonien valmistamiseksi.
FI45551C (fi) Menetelmä terapeuttisesti käytettävän dehydroepiandrosteroniönantaatin valmistamiseksi.
FI45178C (fi) Menetelmä antidiabeettisesti vaikuttavien sulfoniamidien valmistamisek si.
FI47577C (fi) Tapa valmistaa sepelvaltimoita laajentavan vaikutuksen omaavia 2,4,7-t riamino-6-fenyyli-pteridiinejä.
FI46498C (fi) Tapa valmistaa protokatekualdehydin 4-monoalkyylieettereitä.
FI49308C (fi) Menetelmä 6-aminopenisillaanihapon valmistamiseksi.
FI47576C (fi) Menetelmä 2-alkyyliamino-5-fenyyli-3H-1,4-bentsodiatsepiini-4-oksidien valmistamiseksi.
FI46727C (fi) Menetelmä pyridatsolijohdannaisten valmistamiseksi.
NL150783B (nl) Werkwijze ter bereiding van stabiel monoperftaalzuur.
FI45656C (fi) Menetelmä alfa-metyyli-alfa-halogeeni-beta-(3,4-disubstituoitu-fenyyli )propionitriilien valmistamiseksi.
FI47189C (fi) Tapa valmistaa terapeuttisesti vaikuttavia d-lysergiinihappo-N-fenyyli piperatsideja.
FI44620C (fi) Menetelmä sulfamyyliantraniilihappoamidien valmistamiseksi.
FI46963C (fi) Menetelmä antidiabeettisesti vaikuttavien sulfoniamidien valmistamisek si
FI47097C (fi) Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-metyyli-5 -metoksi-3-indolyylietikkahapon valmistamiseksi.
DK136644B (da) Fremgangsmåde til fremstilling af 1-p-chlorbenzoyl-2-methyl-3-indolyl-eddikesyre-forbindelser.
FI48347C (fi) Menetelmä 17beta-alkanoyylioksi-17alfa-propadienyyli-steroidien valmis tamiseksi.
FI45954C (fi) Menetelmä terapeuttisesti vaikuttavien bentseenisulfonyylivirtsa-ainei den valmistamiseksi.
FI51814C (fi) Menetelmä alfa-karboksibentsyylipenisiliinin kielteisen alkalimetallis uolojen valmistamiseksi.
FI48586C (fi) Menetelmä 3-indolyylietikkahappoyhdisteen valmistamiseksi.
FI51356C (fi) Menetelmä cis-propenyylifosfonihapon valmistamiseksi.
FI49162C (fi) Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi.